Stanford, CA 94305
N1 Life, Inc is working on developing new therapeutic strategies against resistant diseases through better delivery technologies. We are a small group of Stanford scientists and industry leaders that are determined to maximize the resources and our knowledge we have and provide better treatment options for patients that are suffering. With our current platform technologies, we are able to deliver small molecule drugs across difficult biological barriers including BBB, skin, resistant cancer cells and bacteria biofilms. Moreover, we have also developed a polymer-based technology for the delivery of gene therapies for various diseases including cancer. Currently we are working on the preclinical development of therapeutics based on our technologies for gynecological cancers and resistant infectious diseases. In the next year, we hope to explore and expand the scope of the application of our technologies and select appropriate indications for further development.